Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reliance Life Sciences has launched five world-first biosimilars with a pipeline of 23 biosimilars in India. The company exports to over 65 countries and is expanding manufacturing capacity for plasma proteins, gene therapies, vaccines and biosimilars. Its product portfolio includes injectables/infusions/tablets/capsules/powders/gels/ointments for diverse therapeutic areas including oncology and chronic disease management. Clinical results are not detailed publicly but commercial presence indicates regulatory approvals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reliance Industries.